Sleep Apnea and Fetal Growth Restriction (SAFER) study: protocol for a pragmatic randomised clinical trial of positive airway pressure as an antenatal therapy for fetal growth restriction in maternal obstructive sleep apnoea

Alex Hincker, Jacob Nadler, Suzanne Karan, Ebony Carter, Shay Porat, Barbara Warner, Yo-El S Ju, Arbi Ben Abdallah, Elizabeth Wilson, Ellen M Lockhart, Yehuda Ginosar, Alex Hincker, Jacob Nadler, Suzanne Karan, Ebony Carter, Shay Porat, Barbara Warner, Yo-El S Ju, Arbi Ben Abdallah, Elizabeth Wilson, Ellen M Lockhart, Yehuda Ginosar

Abstract

Introduction: Fetal growth restriction (FGR) is a major contributor to fetal and neonatal morbidity and mortality with intrauterine, neonatal and lifelong complications. This study explores maternal obstructive sleep apnoea (OSA) as a potentially modifiable risk factor for FGR. We hypothesise that, in pregnancies complicated by FGR, treating mothers who have OSA using positive airway pressure (PAP) will improve birth weight and neonatal outcomes.

Methods and analysis: The Sleep Apnea and Fetal Growth Restriction study is a prospective, block-randomised, single-blinded, multicentre, pragmatic controlled trial. We enrol pregnant women aged 18-50, between 22 and 31 weeks of gestation, with established FGR based on second trimester ultrasound, who do not have other prespecified known causes of FGR (such as congenital anomalies or intrauterine infection). In stage 1, participants are screened by questionnaire for OSA risk. If OSA risk is identified, participants proceed to stage 2, where they undergo home sleep apnoea testing. Participants are determined to have OSA if they have an apnoea-hypopnoea index (AHI) ≥5 (if the oxygen desaturation index (ODI) is also ≥5) or if they have an AHI ≥10 (even if the ODI is <5). These participants proceed to stage 3, where they are randomised to nightly treatment with PAP or no PAP (standard care control), which is maintained until delivery. The primary outcome is unadjusted birth weight; secondary outcomes include fetal growth velocity on ultrasound, enrolment-to-delivery interval, gestational age at delivery, birth weight corrected for gestational age, stillbirth, Apgar score, rate of admission to higher levels of care (neonatal intensive care unit or special care nursery) and length of neonatal stay. These outcomes are compared between PAP and control using intention-to-treat analysis.

Ethics and dissemination: This study has been approved by the Institutional Review Boards at Washington University in St Louis, Missouri; Hadassah Hebrew University Medical Center, Jerusalem; and the University of Rochester, New York. Recruitment began in Washington University in November 2019 but stopped from March to November 2020 due to COVID-19. Recruitment began in Hadassah Hebrew University in March 2021, and in the University of Rochester in May 2021. Dissemination plans include presentations at scientific conferences and scientific publications.

Trial registration number: NCT04084990.

Keywords: maternal medicine; perinatology; sleep medicine.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Sleep Apnea and Fetal Growth Restriction (SAFER) study flow chart. AHI, apnoea-hypopnoea index; BMI, body mass index; FGR, fetal growth restriction; NICU, neonatal intensive care unit; OSA, obstructive sleep apnoea; PAP, positive airway pressure; RCT, randomised controlled trial.
Figure 2
Figure 2
Pragmatic Explanatory Continuum Indicator Summary-2 (PRECIS-2) wheel for characterising the degree to which elements of a study are more explanatory (toward the centre of the wheel) or pragmatic (toward the periphery).

References

    1. Sharma D, Shastri S, Sharma P. Intrauterine growth restriction: antenatal and postnatal aspects. Clin Med Insights Pediatr 2016;10:CMPed.S40070. 10.4137/CMPed.S40070
    1. American College of Obstetricians and Gynecologists Committee on Practice Bulletins—Obstetrics and the Society forMaternal-FetalMedicin . ACOG practice Bulletin No. 204: fetal growth restriction. Obstet Gynecol 2019:e97:133–109. 10.1097/AOG.0000000000003070
    1. Barker DJP. Adult consequences of fetal growth restriction. Clin Obstet Gynecol 2006;49:270–83. 10.1097/00003081-200606000-00009
    1. Pallotto EK, Kilbride HW. Perinatal outcome and later implications of intrauterine growth restriction. Clin Obstet Gynecol 2006;49:257–69. 10.1097/00003081-200606000-00008
    1. Fetal growth restriction: ACOG practice Bulletin, number 227. Obstet Gynecol 2021;137:e16–28. 10.1097/AOG.0000000000004251
    1. Mari G, Hanif F. Intrauterine growth restriction: how to manage and when to deliver. Clin Obstet Gynecol 2007;50:497–509. 10.1097/GRF.0b013e31804c96a9
    1. Hankins GDV, Speer M. Defining the pathogenesis and pathophysiology of neonatal encephalopathy and cerebral palsy. Obstet Gynecol 2003;102:628–36. 10.1016/s0029-7844(03)00574-x
    1. Fang S. Management of preterm infants with intrauterine growth restriction. Early Hum Dev 2005;81:889–900. 10.1016/j.earlhumdev.2005.09.004
    1. Pien GW, Schwab RJ. Sleep disorders during pregnancy. Sleep 2004;27:1405–17. 10.1093/sleep/27.7.1405
    1. Peppard PE, Young T, Barnet JH, et al. . Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 2013;177:1006–14. 10.1093/aje/kws342
    1. Medicine. A.A.o.S. Darien IL. International Classification of Sleep Disorders, 2014.
    1. Iber C, Westchester IL. The American Academy of Sleep Medicine Manual for the scoring of sleep and associated events:rulesterminology and technical specifications, 2007.
    1. Louis J, Auckley D, Miladinovic B, et al. . Perinatal outcomes associated with obstructive sleep apnea in obese pregnant women. Obstet Gynecol 2012;120:1085–92. 10.1097/AOG.0b013e31826eb9d8
    1. Chen Y-H, Kang J-H, Lin C-C, et al. . Obstructive sleep apnea and the risk of adverse pregnancy outcomes. Am J Obstet Gynecol 2012;206:136.e1–136.e5. 10.1016/j.ajog.2011.09.006
    1. Pamidi S, Pinto LM, Marc I, et al. . Maternal sleep-disordered breathing and adverse pregnancy outcomes: a systematic review and metaanalysis. Am J Obstet Gynecol 2014;210:p. 52 e1–52. 10.1016/j.ajog.2013.07.033
    1. Izci-Balserak B, Pien GW. Sleep-Disordered breathing and pregnancy: potential mechanisms and evidence for maternal and fetal morbidity. Curr Opin Pulm Med 2010;16:574–82. 10.1097/MCP.0b013e32833f0d55
    1. Louis JM, Mogos MF, Salemi JL, et al. . Obstructive sleep apnea and severe maternal-infant morbidity/mortality in the United States, 1998-2009. Sleep 2014;37:843–9. 10.5665/sleep.3644
    1. Izci Balserak B, Jackson N, Ratcliffe SA, et al. . Sleep-Disordered breathing and daytime napping are associated with maternal hyperglycemia. Sleep Breath 2013;17:1093–102. 10.1007/s11325-013-0809-4
    1. Facco FL, Ouyang DW, Zee PC, et al. . Sleep disordered breathing in a high-risk cohort prevalence and severity across pregnancy. Am J Perinatol 2014;31:899-904. 10.1055/s-0033-1363768
    1. Facco FL, Ouyang DW, Zee PC, et al. . Development of a pregnancy-specific screening tool for sleep apnea. J Clin Sleep Med 2012;8:389–94. 10.5664/jcsm.2030
    1. Olivarez SA, Ferres M, Antony K, et al. . Obstructive sleep apnea screening in pregnancy, perinatal outcomes, and impact of maternal obesity. Am J Perinatol 2011;28:651–8. 10.1055/s-0031-1276740
    1. Facco FL. Sleep-Disordered breathing and pregnancy. Semin Perinatol 2011;35:335–9. 10.1053/j.semperi.2011.05.018
    1. Dominguez JE, Lockhart EM, Miskovic A, et al. . Recognition of obstructive sleep apnea in pregnancy survey. Int J Obstet Anesth 2016;26:85–7. 10.1016/j.ijoa.2016.01.003
    1. Karan S, Ginosar Y. Gestational sleep apnea: have we been caught napping? Int J Obstet Anesth 2016;26:1–3. 10.1016/j.ijoa.2016.03.001
    1. Lavie L. Oxidative stress in obstructive sleep apnea and intermittent hypoxia--revisited--the bad ugly and good: implications to the heart and brain. Sleep Med Rev 2015;20:27–45. 10.1016/j.smrv.2014.07.003
    1. Ginosar Y, Gielchinsky Y, Nachmansson N, et al. . BOLD-MRI demonstrates acute placental and fetal organ hypoperfusion with fetal brain sparing during hypercapnia. Placenta 2018;63:53–60. 10.1016/j.placenta.2017.09.005
    1. Sahin FK, Koken G, Cosar E, et al. . Obstructive sleep apnea in pregnancy and fetal outcome. Int J Gynaecol Obstet 2008;100:141–6. 10.1016/j.ijgo.2007.08.012
    1. Olivarez SA, Maheshwari B, McCarthy M, et al. . Prospective trial on obstructive sleep apnea in pregnancy and fetal heart rate monitoring. Am J Obstet Gynecol 2010;202:552.e1–552.e7. 10.1016/j.ajog.2009.12.008
    1. Xu T, Li T, Wei D, et al. . Effect of automatic versus fixed continuous positive airway pressure for the treatment of obstructive sleep apnea: an up-to-date meta-analysis. Sleep Breath 2012;16:1017–26. 10.1007/s11325-011-0626-6
    1. Guo J, Sun Y, Xue L-J, et al. . Effect of CPAP therapy on cardiovascular events and mortality in patients with obstructive sleep apnea: a meta-analysis. Sleep Breath 2016;20:965–74. 10.1007/s11325-016-1319-y
    1. Qureshi WT, Nasir UB, Alqalyoobi S, et al. . Meta-Analysis of continuous positive airway pressure as a therapy of atrial fibrillation in obstructive sleep apnea. Am J Cardiol 2015;116:1767–73. 10.1016/j.amjcard.2015.08.046
    1. Donovan LM, Boeder S, Malhotra A, et al. . New developments in the use of positive airway pressure for obstructive sleep apnea. J Thorac Dis 2015;7:1323–42. 10.3978/j.issn.2072-1439.2015.07.30
    1. Feng Y, Zhang Z, Dong Z-zhou. Effects of continuous positive airway pressure therapy on glycaemic control, insulin sensitivity and body mass index in patients with obstructive sleep apnoea and type 2 diabetes: a systematic review and meta-analysis. NPJ Prim Care Respir Med 2015;25:15005. 10.1038/npjpcrm.2015.5
    1. Sassani A, Findley LJ, Kryger M, et al. . Reducing motor-vehicle collisions, costs, and fatalities by treating obstructive sleep apnea syndrome. Sleep 2004;27:453–8. 10.1093/sleep/27.3.453
    1. Blyton DM, Sullivan CE, Edwards N. Reduced nocturnal cardiac output associated with preeclampsia is minimized with the use of nocturnal nasal CPAP. Sleep 2004;27:79–84. 10.1093/sleep/27.1.79
    1. Edwards N, Blyton DM, Kirjavainen T, et al. . Nasal continuous positive airway pressure reduces sleep-induced blood pressure increments in preeclampsia. Am J Respir Crit Care Med 2000;162:252–7. 10.1164/ajrccm.162.1.9905006
    1. Chan A-W, Tetzlaff JM, Altman DG, et al. . Spirit 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med 2013;158:200–7. 10.7326/0003-4819-158-3-201302050-00583
    1. Lockhart EM, Ben Abdallah A, Tuuli MG, et al. . Obstructive sleep apnea in pregnancy: assessment of current screening tools. Obstet Gynecol 2015;126:93–102. 10.1097/AOG.0000000000000848
    1. Izci-Balserak B, Zhu B, Gurubhagavatula I, et al. . A screening algorithm for obstructive sleep apnea in pregnancy. Ann Am Thorac Soc 2019;16:1286–94. 10.1513/AnnalsATS.201902-131OC
    1. Phurrough S JL, Stiller J, Brechner R. Decision Memo for SLEEP TESTING for Obstructive SLEEP Apnea (OSA) (CAG-00405N), 2009. C.f.M.a.M.Government services us
    1. Berry RB, Budhiraja R, Gottlieb DJ, et al. . Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. deliberations of the sleep apnea definitions Task force of the American Academy of sleep medicine. J Clin Sleep Med 2012;8:597–619. 10.5664/jcsm.2172
    1. Kapur VK, Auckley DH, Chowdhuri S, et al. . Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of sleep medicine clinical practice guideline. J Clin Sleep Med 2017;13:479–504. 10.5664/jcsm.6506
    1. American Hospital Association . Positive Airway Pressure (PAP) Devices for the Treatment of Obstructive Sleep Apnea 2020.
    1. Grantz KL, Kim S, Grobman WA, et al. . Fetal growth velocity: the NICHD fetal growth studies. Am J Obstet Gynecol 2018;219:p. 285 e1–285. 10.1016/j.ajog.2018.05.016
    1. Oken E, Kleinman KP, Rich-Edwards J, et al. . A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr 2003;3:6. 10.1186/1471-2431-3-6
    1. Novak GP, Kurtzberg D, Kreuzer JA, et al. . Cortical responses to speech sounds and their formants in normal infants: maturational sequence and spatiotemporal analysis. Electroencephalogr Clin Neurophysiol 1989;73:295–305. 10.1016/0013-4694(89)90108-9
    1. Smith GCS. Antenatal betamethasone for women at risk for late preterm delivery. N Engl J Med 2016;375:486. 10.1056/NEJMc1605902
    1. Adamkin DH, Committee on Fetus and Newborn . Postnatal glucose homeostasis in late-preterm and term infants. Pediatrics 2011;127:575–9. 10.1542/peds.2010-3851
    1. Facco FL, Ouyang DW, Zee PC, et al. . Sleep disordered breathing in a high-risk cohort prevalence and severity across pregnancy. Am J Perinatol 2014;31:899–904. 10.1055/s-0033-1363768
    1. Bourjeily G, Fung JY, Sharkey KM, et al. . Airflow limitations in pregnant women suspected of sleep-disordered breathing. Sleep Med 2014;15:550-5. 10.1016/j.sleep.2014.01.004
    1. Pandey A, Mereddy S, Combs D, et al. . Socioeconomic inequities in adherence to positive airway pressure therapy in population-level analysis. J Clin Med 2020;9. 10.3390/jcm9020442. [Epub ahead of print: 06 02 2020].
    1. McCowan LM, Figueras F, Anderson NH. Evidence-Based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy. Am J Obstet Gynecol 2018;218:S855–68. 10.1016/j.ajog.2017.12.004
    1. Reid ML, Gleason KJ, Bakker JP, et al. . The role of sham continuous positive airway pressure as a placebo in controlled trials: best apnea interventions for research trial. Sleep 2019;42. 10.1093/sleep/zsz099. [Epub ahead of print: 01 08 2019].
    1. Patel SR, Bakker JP, Stitt CJ, et al. . Age and sex disparities in adherence to CPAP. Chest 2021;159:382–9. 10.1016/j.chest.2020.07.017
    1. Hadlock FP, Deter RL, Harrist RB, et al. . Estimating fetal age: computer-assisted analysis of multiple fetal growth parameters. Radiology 1984;152:497–501. 10.1148/radiology.152.2.6739822
    1. Alexander GR, Himes JH, Kaufman RB, et al. . A United States national reference for fetal growth. Obstet Gynecol 1996;87:163–8. 10.1016/0029-7844(95)00386-X
    1. Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr 2013;13:59. 10.1186/1471-2431-13-59
    1. Hadlock FP, Harrist RB, Sharman RS, et al. . Estimation of fetal weight with the use of head, body, and femur measurements--a prospective study. Am J Obstet Gynecol 1985;151:333–7. 10.1016/0002-9378(85)90298-4
    1. Sheth T, Glantz JC. Third-Trimester fetal biometry and neonatal outcomes in term and preterm deliveries. J Ultrasound Med 2016;35:103–10. 10.7863/ultra.15.02040
    1. Durie DE, Thornburg LL, Glantz JC. Effect of second-trimester and third-trimester rate of gestational weight gain on maternal and neonatal outcomes. Obstet Gynecol 2011;118:569–75. 10.1097/AOG.0b013e3182289f42
    1. Stirnemann J, Villar J, Salomon LJ, et al. . International estimated fetal weight standards of the INTERGROWTH-21st Project. Ultrasound Obstet Gynecol 2017;49:478–86. 10.1002/uog.17347
    1. Dollberg S, Haklai Z, Mimouni FB. Birth weight standards in the live-born population in Israel. Isr Med Assoc J 2005;7:311–4.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren